InvestorsHub Logo
Followers 156
Posts 6362
Boards Moderated 1
Alias Born 08/06/2004

Re: None

Saturday, 02/18/2023 9:16:43 PM

Saturday, February 18, 2023 9:16:43 PM

Post# of 460703
I have never posted WGT; however I have observed the more important WGT from the company PR:

ANAVEX®2–73 (Blarcamesine) Phase 2B/3 Study Met Primary and Key Secondary Endpoints, Showing Statistically Significant Reduction of Clinical Decline in Global Clinical Study of Patients With Early Alzheimer’s Disease



Robust, Statistically Significant and Clinically Meaningful Absolute Improvement in Cognitive Function as Measured by ADAS-Cog and ADCS-ADL

Key Secondary Endpoint CDR-SB Also Met, Demonstrating Statistically Significant Results

Plan to Meet with Regulatory Authorities to Determine Next Steps



A logical conclusion is the company is not lying, because if they are the company would face investigations and multiple law suits; and Missling's name, professional career, and standing in the biotech world would be ruined. His stock and options would be nearly worthless.

The odds overwhelmingly indicating the company is telling the truth.

Anavex is saying WGT.
Are they lying? I don't think so.

https://finance.yahoo.com/news/anavex-2-73-blarcamesine-phase-012600796.html

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News